Study Identifies 6 Components of a Pregnancy Exercise Program that Reduce Risk of Poor Perinatal Outcomes
While exercise is beneficial during pregnancy and ACOG recommends 150 mins/week, this is the first study to examine benefits of specific regimen elements on their own.
Fezolinetant Demonstrates Reduced Waist Circumference, Body Roundness and Stable Weight and BMI in 52-Week Pooled Analysis of Phase 3 SKYLIGHT Trials
Postmenopausal women taking fezolinetant experienced positive changes in body fat distribution, increases in which are known to increase risks of cardiometabolic disease.
Elinzanetant Demonstrates Clinically Meaningful Reductions in Menopausal Vasomotor Symptoms, Meta-analysis Shows
Elinzanetant reduced VMS frequency and intensity, and improved sleep and quality of life, according to the meta-analysis to be presented at the ACOG 2025 meeting.
Normalizing Mental Health: A Vital Sign in Prenatal and Postpartum Care
The Role of Primary Care in Women's Health With Laurence Shields, MD
The two areas where primary care physicians can contribute to improving women's health, according to Laurence Shields, MD.
ACOG 2025 Refresh: Menopausal VMS Education in Primary Care
Building trust with patients early on will help them feel comfortable discussing their symptoms and treatment preferences, says JoAnn Pinkerton, MD.
ACOG opens 2025 Annual Clinical & Scientific Meeting, 'Powered by Purpose,' in Minneapolis
ACOG Issues Consensus Guidance to Improve Pain Control During In-Office Gynecologic Procedures
Every patient should be offered evidence-based analgesia for pain management for in-office uterine and cervical procedures after shared, trauma-informed decision-making.
TikTok Videos Found Inaccurate on Birth Control but Tweet Volume Appears Authoritative on Endometrial Cancer
More than half of TikTok videos reviewed on hormonal birth control were patient-created and misleading while the majority of posts on endometrial cancer were by clinicians.
Majority of Pregnant Patients Accepted RSV Protection in Vaccine's First Season
Two-thirds of pregnant individuals opted for either maternal vaccination against RSV or for neonatal monoclonal antibody therapy and for other vaccines recommended in pregnancy.
ACOG 2025: Menopause and Vasomotor Symptoms Preview
A preview of sessions covering menopause and vasomotor symptoms during ACOG 2025 in Minneapolis, MN.
Low Uptake of Hereditary Cancer Screening Among Breast Cancer Survivors Highlights Missed Opportunities for Preventive Care
In a cancer survivorship clinic in urban New York, only one-quarter of long-term breast cancer survivors received genetic testing, contrary to current recommendations.
For Recurrent Bacterial Vaginosis, Simplified Once-Weekly Treatment Found More Effective than CDC-Recommended Regimen
Secnidazole granules reduced recurrence rates to 20% over a period of 28 weeks in a small prospective pilot study, outperforming cumbersome daily regimens.
Cannabis-Related ED Visits May Raise Dementia Risk: Daily Dose
Your daily dose of the clinical news you may have missed.
Evidence for Adverse Effects of High-Dose GC Treatment of Congenital Adrenal Hyperplasia Broadened, Deepened in New Literature Review
The most commonly reported adverse effects of high-dose glucocorticoid therapy were on bone health, cardiometabolic function, and height and growth.
Oral Gepotidacin Rivals Standard Gonorrhea Regimen in Trial: Daily Dose
Atopic Dermatitis Treatment Caution: Long-Term Oral Corticosteroid Use Ups Cardiovascular and Thrombotic Risks
The potential cardiovascular impact of prolonged oral corticosteroid therapy in the AD population observed in this study confirms longstanding cautions.
Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis
Semaglutide was associated with a significant reduction in risk for major adverse cardiovascular events after just 3 months of treatment in a population with established CVD.
Bone Loss Slowed in Women on Med Diet, Exercise Plan: Daily Dose
Managing Vasomotor Symptoms of Menopause: A Topline Comparison of Treatments
Medical and nonpharmacologic treatment options for VMS range in efficacy and risk/benefit profile; a short slide show offers a topline look at how many compare.
.JPG%3Ffit%3Dcrop%26auto%3Dformat&w=3840&q=75 "Semaglutide Linked to Reduced Risk for MACE Months Before Weight Loss Begins: Post Hoc Analysis / image credit Jorge Plutzky, MD, Brigham and Women's Hospital")
